Zepp Health (ZEPP) Income Statement (2015 - 2023)
Annual Income Statement report data from Dec 31, 2015 to Dec 31, 2023 for Zepp Health (ZEPP) in CNY with ability to convert in USD.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | |||||||||
Total Revenue | 2.50B (-39.77%) | 4.14B (-33.72%) | 6.25B (-2.85%) | 6.43B (+10.69%) | 5.81B (+59.44%) | 3.65B (+77.92%) | 2.05B (+31.64%) | 1.56B (+73.63%) | 896M |
Cost Of Revenue | 1.84B (-44.98%) | 3.34B (-32.45%) | 4.94B (-3.06%) | 5.10B (+17.41%) | 4.34B (+60.56%) | 2.71B (+74.10%) | 1.55B (+21.39%) | 1.28B (+62.92%) | 786M |
Costof Goods And Services Sold | 1.84B (-44.98%) | 3.34B (-32.45%) | 4.94B (-3.06%) | 5.10B (+17.41%) | 4.34B (+60.56%) | 2.71B (+74.10%) | 1.55B (+21.39%) | 1.28B (+62.92%) | 786M |
Gross Profit | 658M (-18.10%) | 803M (-38.49%) | 1.31B (-2.03%) | 1.33B (-9.20%) | 1.47B (+56.23%) | 939M (+89.90%) | 495M (+79.14%) | 276M (+149.71%) | 111M |
Operating Expenses | |||||||||
Research And Development | 362M (-30.03%) | 517M (+0.40%) | 515M (-4.26%) | 538M (+24.88%) | 431M (+63.67%) | 263M (+71.11%) | 154M (+16.27%) | 132M (+114.95%) | 62M |
Selling General And Administrative | 189M (-20.10%) | 236M (-8.68%) | 258M (-1.32%) | 262M (+5.37%) | 248M (+16.12%) | 214M (+86.26%) | 115M (+11.93%) | 103M (+46.67%) | 70M |
Operating Expenses | 865M (-28.72%) | 1.21B (+0.14%) | 1.21B (+4.59%) | 1.16B (+34.51%) | 861M (+50.12%) | 574M (+83.46%) | 313M (+19.01%) | 263M (+74.35%) | 151M |
Depreciation And Amortization | 54M (-7.11%) | 59M (+12.99%) | 52M (+91.23%) | 27M (+57.55%) | 17M (+176.85%) | 6.22M (+75.71%) | 3.54M (+47.50%) | 2.40M (+757.14%) | 280K |
Operating Income | |||||||||
Operating Income | -207.10M (-49.52%) | -410.24M | 94M (-46.07%) | 174M (-71.28%) | 606M (+65.83%) | 366M (+100.98%) | 182M (+1260.01%) | 13M | -40.11M |
Ebit | -207.10M (-49.52%) | -410.24M | 94M (-46.07%) | 174M (-71.28%) | 606M (+65.83%) | 366M (+100.98%) | 182M (+1260.01%) | 13M | -40.11M |
EBITDA | -152.65M (-56.59%) | -351.62M | 146M (-27.57%) | 201M (-67.72%) | 624M (+67.69%) | 372M (+100.50%) | 186M (+1075.60%) | 16M | -39.83M |
Other Income / Expenses | |||||||||
Interest Expense | 48M (-16.32%) | 57M (+27.01%) | 45M (+98.41%) | 23M | - | - | - | - | - |
Net Interest Income | -47.70M (-16.32%) | -57.00M (+27.01%) | -44.88M (+98.41%) | -22.62M | - | - | - | - | - |
Net Income | |||||||||
Income Tax Expense | -15.82M (-75.98%) | -65.87M | 11M (-65.49%) | 31M (-60.01%) | 78M (+49.67%) | 52M (+88.48%) | 28M (+793.53%) | 3.09M | -900.00K |
Net Income From Continuing Operations | -212.12M (-26.43%) | -288.31M | 138M (-39.76%) | 229M (-60.23%) | 575M (+69.15%) | 340M (+102.80%) | 168M (+600.13%) | 24M | -37.85M |
Net Income | -212.12M (-26.43%) | -288.31M | 138M (-39.76%) | 229M (-60.23%) | 575M (+69.15%) | 340M (+102.80%) | 168M (+600.13%) | 24M | -37.85M |
Comprehensive Income Net Of Tax | -221.59M (+4.63%) | -211.78M | 122M (-24.55%) | 162M (-72.45%) | 589M (+41.93%) | 415M (+138.57%) | 174M (+489.60%) | 30M | -27.63M |